- The company’s corporate mission is to cultivate the world’s best cannabis
- Supreme Cannabis emphasizes quality products, synergistic industry partnerships and strong distribution networks
- Supreme Cannabis’ multi-pronged strategy has positioned it for continued growth
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is working to improve global well-being with cannabis. Since 2014, the company has been at the center of the cannabis space with a mission of cultivating the globe’s best product and emerging as a leader in this worldwide industry. Headquartered in Toronto, Ontario, Supreme Cannabis Company uses its knowledge of the plant to create transformative businesses, products and brands that deliver positive experiences.
One important avenue of the company’s growth is through its 7ACRES subsidiary, which is its flagship brand. 7ACRES is on course to become Canada’s foremost cultivator of consistently premier cannabis, in no small part due to its facility’s focus on building a core competency in scaled cannabis production. 7ACRES grows High End Cannabis(TM) with respect to each cultivar’s genetic lineage and history. SPRWF takes pride in its flagship brand (http://ibn.fm/DCylh), which respects its customers’ knowledge of cannabis and recognizes their desire for “hand-crafted cannabis flower that delivers an uncompromised experience.”
7ACRES operates a 440,000-square-foot facility in Kincardine, Ontario. This cultivation facility is one of Canada’s first 40 federally licensed cannabis producers (http://ibn.fm/gppgi). As of March 2019, the facility’s total licensed cultivation space spanned 230,000 square feet. 7ACRES provides consumers with handcrafted cannabis flower, and its cultivars are available in eight Canadian provinces, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia and Prince Edward Island.
Each of SPRWF’s operating assets is very focused and aims to achieve excellence at its core function. With 7ACRES, the company has created a business that produces the highest quality premium cannabis at scale. With the recent launch of Cambium Plant Sciences, a cannabis genetics firm located in Goderich, Ontario, Supreme Cannabis further focused 7ACRES’ operations, spinning out its successful genetics business into its own company. The company is investing approximately $14 million in the construction of a state-of-the-art, 34,000-square-foot research and development facility. Cambium’s aim is to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the international cannabis industry.
SPRWF continue to focus on the creation of valuable cannabis intellectual property (IP). “Our proprietary genetics selection methodology and ability to cultivate high-end cannabis at scale at 7ACRES has created strong industry demand for our proprietary genetics and cultivation techniques,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release (http://ibn.fm/adRCd). “It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market. We believe genetics are the foundation of proprietary cannabis products in the long term.”
Industry analysts point to developing intellectual property as a critical component to cannabis companies’ long-term vitality. In an industry where legislation is struggling to keep up with the booming demand for high-quality products, fledgling companies fear having their technologies, brands, recipes, and secrets “ripped off” by competitors (http://ibn.fm/G8L5o). Aside from protecting companies and lending them a competitive edge, early developed IP rights have been deemed “indispensable,” linked with generating “additional recurring revenue, help[ing] attract investment, and enhance[ing] valuation.” SPRWF’s continued efforts to develop IP are key to its strategic growth and longevity.
Most recently, the company acquired Truverra Inc., which plans to repurpose its 5,000-square-foot, state-of-the-art space to produce high-quality cannabis extracts, including concentrates and vaping liquids. With an already established line of efficacy-based CBD products being sold in the United Kingdom, Truverra is helping SPRWF make inroads into the global marketplace. The company features a line of CBD products varying in flavor and intensity, and its products are available in many forms, including capsules, creams and balms, e-liquids, oils and supplements (http://ibn.fm/WQb1t).
With its culture of innovation in producing excellent products, Supreme Cannabis Company offers investors a gateway into the cannabis space. With its existing premium brands and products and impressive innovations across its businesses, Supreme is positioned for continued growth.
For more information, visit the company’s website at www.Supreme.ca
NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF